Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Matthew W, Lyerly"'
Autor:
Mary K Young, Jhansi L Leslie, Gregory R Madden, David M Lyerly, Robert J Carman, Matthew W Lyerly, David B Stewart, Mayuresh M Abhyankar, William A Petri
Publikováno v:
Open Forum Infectious Diseases. 9
Background The incidence of Clostridioides difficile infection (CDI) has increased over the past 2 decades and is considered an urgent threat by the Centers for Disease Control and Prevention. Hypervirulent strains such as ribotype 027, which possess
Autor:
Mary K, Young, Jhansi L, Leslie, Gregory R, Madden, David M, Lyerly, Robert J, Carman, Matthew W, Lyerly, David B, Stewart, Mayuresh M, Abhyankar, William A, Petri
Publikováno v:
Open forum infectious diseases. 9(3)
The incidence ofWe retrospectively tested stool from 215 CDI patients for CDT by enzyme-linked immunosorbent assay (ELISA). Stratifying patients by CDT status, we assessed if disease severity and clinical outcomes correlated with CDT positivity. Addi
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:2525-2530
Clostridium difficile infection (CDI) is a gastrointestinal disease caused by C. difficile , a spore-forming bacterium that in its spore form is tolerant to standard antimicrobials. Ramoplanin is a glycolipodepsipeptide antibiotic that is active agai
Autor:
Matthew W. Lyerly, Adam L. Stevens, Megan F. Hiltonsmith, Robert J. Carman, Tracy D. Wilkins, Bradley G. Stiles
Publikováno v:
Anaerobe. 17(4)
Clostridium difficile is a major enteropathogen of humans. It produces two main virulence factors, toxins A and B. A third, less well known toxin, C. difficile toxin (CDT), is a binary toxin composed of distinct enzymatic (CdtA) and cell binding/tran